Cells (Feb 2024)

Cellular Senescence, Mitochondrial Dysfunction, and Their Link to Cardiovascular Disease

  • Maria Camacho-Encina,
  • Laura K. Booth,
  • Rachael E. Redgrave,
  • Omowumi Folaranmi,
  • Ioakim Spyridopoulos,
  • Gavin D. Richardson

DOI
https://doi.org/10.3390/cells13040353
Journal volume & issue
Vol. 13, no. 4
p. 353

Abstract

Read online

Cardiovascular diseases (CVDs), a group of disorders affecting the heart or blood vessels, are the primary cause of death worldwide, with an immense impact on patient quality of life and disability. According to the World Health Organization, CVD takes an estimated 17.9 million lives each year, where more than four out of five CVD deaths are due to heart attacks and strokes. In the decades to come, an increased prevalence of age-related CVD, such as atherosclerosis, coronary artery stenosis, myocardial infarction (MI), valvular heart disease, and heart failure (HF) will contribute to an even greater health and economic burden as the global average life expectancy increases and consequently the world’s population continues to age. Considering this, it is important to focus our research efforts on understanding the fundamental mechanisms underlying CVD. In this review, we focus on cellular senescence and mitochondrial dysfunction, which have long been established to contribute to CVD. We also assess the recent advances in targeting mitochondrial dysfunction including energy starvation and oxidative stress, mitochondria dynamics imbalance, cell apoptosis, mitophagy, and senescence with a focus on therapies that influence both and therefore perhaps represent strategies with the most clinical potential, range, and utility.

Keywords